GPP
PTX

Great Point Partners’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Great Point Partners’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-29,681
Closed -$807K – 40
2013
Q3 		$807K Buy
+29,681
New +$955K 0.56% 27

Other funds holding PTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SC
Sageview Capital Greenwich, Connecticut $177M AUM 36.56% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Great Point Partners's PTX Position: Q4 2013 in Review

Great Point Partners sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2013, closing a stake of 29,681 shares — an estimated $807K sold.

Great Point Partners first reported a position in PTX in Q3 2013 and held it in 1 quarter. The position peaked at $807K in Q3 2013. 43 funds tracked by Wall St. Rank hold PTX as of Q4 2013.

  • Great Point Partners reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2013 after selling out during the quarter.
  • Great Point Partners sold 29,681 Pernix Therapeutics Holdings, Inc. shares in Q4 2013, an estimated $807K.
  • Great Point Partners first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2013 and held it in 1 quarter.
  • Great Point Partners's Pernix Therapeutics Holdings, Inc. position peaked at $807K in Q3 2013.
  • 43 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2013.

Based on Great Point Partners's 13F filing for Q4 2013, filed 14 Feb 2014.